Effective procurement of tissues and other biospecimens, and their optimal utilization is vital for? meaningful translational research activities. The goal of the Biospecimen, Pathology and? Genotyping Core is to work with each SPORE research project and the Analytical Core to ensure? efficient and highly coordinated procurement, use and storage of human biosamples. The Core will? obtain and maintain a repository of biospecimens (including tumor tissue, premalignant tissue,? adjacent non-malignant tissue), serum, plasma, peripheral blood lymphocytes (including lymphoblastoid? cell lines) and their derivates such as DMA and RNA samples for laboratory use, with an effective? coding system for all laboratory specimens to ensure patient confidentiality and prevent experimental? bias. Continuous communication between the surgeons, research nurses, biostatisticians and? pathologists, as well as standardized operating procedures for activities will provide for optimal? biospecimen collection and accurate processing, analysis and storage of each sample. Samples will be? prepared for genotyping in an efficient manner in a CLIA certified laboratory that assures good quality? control while ensuring that these precious materials are not wasted. Thus, the functions of the? Biospecimen, Pathology and Genotyping Core are to facilitate acquisition, preservation, analysis and? dispersal of well-annotated clinical samples and to provide histopathologic characterization of tumor? tissues for all project investigators. Currently, the Human Tissue Research Core facility and the DNA? Sequencing and Genotyping Core Facility, shared resources of the University of Chicago Cancer? Center, provide normal and neoplastic human tissues as well as genotyping services for cancer? research, and are resources of expertise, collaborative support, and service for pathology,? immunohistochemistry, laser capture microdissection, tissue microarray preparation, nucleic acid? extraction and genomics analyses. The Biospecimen, Pathology and Genotyping Core of the? Breast Cancer SPORE will be integrated with the existing Shared Resources in order to provide a? coordinated, centralized, dedicated program for procuring, processing, and assessing biospecimens? and patient data from breast cancer patients and to provide these specimens for research projects? within the Breast SPORE and to other investigators with translational breast cancer research projects.? This CORE will interact closely with the Analytic and Bio-informatics Core of this SPORE to integrate? data into a single database and to provide specimens that meet the statistical requirements for breast? cancer translational research projects supported by this SPORE.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA125183-03
Application #
7668457
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
3
Fiscal Year
2008
Total Cost
$331,364
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Guindalini, Rodrigo Santa; Zheng, Yonglan; Abe, Hiroyuki et al. (2018) Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers. Clin Cancer Res :
Rebbeck, Timothy R (see original citation for additional authors) (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593-620
Zheng, Yonglan; Walsh, Tom; Gulsuner, Suleyman et al. (2018) Inherited Breast Cancer in Nigerian Women. J Clin Oncol 36:2820-2825
Wang, Shengfeng; Ogundiran, Temidayo; Ademola, Adeyinka et al. (2018) Development of a Breast Cancer Risk Prediction Model for Women in Nigeria. Cancer Epidemiol Biomarkers Prev 27:636-643
Debiasi, Márcio; Polanczyk, Carisi A; Ziegelmann, Patrícia et al. (2018) Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis. Front Oncol 8:156
Feng, Ye; Rhie, Suhn Kyong; Huo, Dezheng et al. (2017) Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiol Biomarkers Prev 26:1016-1026
Hamdi, Yosr; Soucy, Penny; Kuchenbaeker, Karoline B et al. (2017) Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Res Treat 161:117-134
Michailidou, Kyriaki (see original citation for additional authors) (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551:92-94
Rudin, Shoshana; Marable, Marcus; Huang, R Stephanie (2017) The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment. Genomics Proteomics Bioinformatics 15:82-93
Geeleher, Paul; Huang, R Stephanie (2017) Exploring the Link between the Germline and Somatic Genome in Cancer. Cancer Discov 7:354-355

Showing the most recent 10 out of 203 publications